Drug Type Peptide Conjugate Radionuclide, Diagnostic radiopharmaceuticals |
Synonyms- |
Target |
Action inhibitors |
Mechanism MMP14 inhibitors(Matrix metalloproteinase 14 inhibitors), MT1 inhibitors(ALG1 chitobiosyldiphosphodolichol beta-mannosyltransferase inhibitors) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
License Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Glioma | Preclinical | China | 25 Aug 2025 | |
Pancreatic Cancer | Preclinical | China | 25 Aug 2025 |